← Open Payments lookup

STEPHANIE MCLAUGHLIN: Open Payments

NPI 1508447939 · MADISON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,195 in 114 payments from 15 companies in 2025. Trend: 2023 $2,995 · 2024 $2,924 · 2025 $2,195

Food & beverage: $2,195
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)23$361
ABBVIE INC.24$352
Alkermes, Inc.12$292
Neurocrine BioSciences, Inc.10$271
Corium, LLC12$241
Takeda Pharmaceuticals U.S.A., Inc.7$138
Otsuka America Pharmaceutical, Inc.7$136
Teva Pharmaceuticals USA, Inc.4$83
Janssen Pharmaceuticals, Inc4$73
Indivior Inc.2$67

Products named: CAPLYTA, VRAYLAR, INGREZZA, ARISTADA, Azstarys, TRINTELLIX, REXULTI, AUSTEDO XR.

Industry payments across AL — which companies pay providers there.